Aug 27, 2026 09:01AM
Aug 27, 2026 09:01AM
Aug 24, 2026 09:05AM
Aug 24, 2026 09:05AM
Jun 18, 2026 08:32AM
Jun 18, 2026 08:31AM
May 18, 2026 09:15AM GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
May 14, 2026 08:35AM
May 14, 2026 08:35AM
Feb 5, 2026 09:15AM
Feb 4, 2026 08:47AM
Feb 4, 2026 08:45AM
Jan 28, 2026 08:45AM
Jan 28, 2026 08:45AM GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF
Jan 26, 2026 08:30AM
Jan 21, 2026 04:01PM
Jan 21, 2026 04:01PM
Jan 8, 2026 08:00AM
Jan 8, 2026 08:00AM
Dec 12, 2025 04:05PM
Dec 12, 2025 04:05PM GRI Bio Announces Closing of $8.0 Million Public Offering
Dec 11, 2025 09:15AM
Dec 11, 2025 09:15AM
Dec 10, 2025 04:05PM
Dec 10, 2025 04:05PM
Sep 11, 2025 08:45AM
Sep 11, 2025 08:45AM
Jul 31, 2025 09:00AM GRI Bio reports interim biomarker data from phase 2a IPF study
Jul 31, 2025 09:00AM
Jul 1, 2025 08:45AM
Jun 26, 2025 08:08AM
Jun 26, 2025 08:00AM
May 22, 2025 08:03AM
May 22, 2025 08:00AM
May 15, 2025 08:35AM GRI Bio, Inc (GRI) Confirms GRI-0621 Phase 2a IPF Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025
May 15, 2025 08:35AM
May 8, 2025 08:48AM
May 8, 2025 08:45AM
May 7, 2025 09:15AM
Apr 16, 2025 08:35AM
Apr 2, 2025 04:05PM
Apr 1, 2025 11:15AM GRI Bio, Inc (GRI) Announces Pricing of $5.0 Million Public Offering
Apr 1, 2025 11:15AM
Apr 1, 2025 09:00AM
Apr 1, 2025 09:00AM
Mar 31, 2025 08:03AM
Mar 31, 2025 08:00AM
Mar 18, 2025 09:05AM
Mar 17, 2025 08:05AM GRI Bio Reports Full Year 2024 Financial Results and Reiterates Expected Clinical Data Readouts in 2025 for Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
Mar 11, 2025 08:35AM

1,185,844 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All